Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Annexon (ANNX) Research & Development (2019 - 2026)

Annexon's Research & Development history spans 8 years, with the latest figure at $35.8 million for Q1 2026.

  • Quarterly Research & Development fell 25.72% to $35.8 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $172.3 million through Mar 2026, up 17.48% year-over-year, with the annual reading at $184.7 million for FY2025, 54.63% up from the prior year.
  • Research & Development came in at $35.8 million for Q1 2026, down from $42.7 million in the prior quarter.
  • In the past five years, Research & Development ranged from a high of $49.7 million in Q3 2025 to a low of $21.0 million in Q1 2024.
  • The 5-year median for Research & Development is $30.1 million (2024), against an average of $33.3 million.
  • Year-over-year, Research & Development tumbled 35.19% in 2024 and then soared 129.83% in 2025.
  • Annexon's Research & Development stood at $28.5 million in 2022, then fell by 18.46% to $23.3 million in 2023, then skyrocketed by 86.33% to $43.4 million in 2024, then dropped by 1.6% to $42.7 million in 2025, then dropped by 16.11% to $35.8 million in 2026.
  • Per Business Quant, the three most recent readings for ANNX's Research & Development are $35.8 million (Q1 2026), $42.7 million (Q4 2025), and $49.7 million (Q3 2025).